AI is starting to “know” your drug the way investors do. The question is: do you know what it knows?
In pharma, we’ve spent years building competitive moats around data—clinical readouts, label language, patent estates, manufacturing constraints, payer…

Most pharma teams don’t lose because they lack talent. They lose because they’re looking at the wrong “clock.”
In patent strategy, timing isn’t just a timeline—it’s a competitive weapon. The difference between winning and getting boxed out often comes …

The biologics patent war isn’t a single battle—it’s two systems fighting over the same prize.
If you’ve ever wondered why blockbuster biologics can feel like they’re locked in a decades-long chess match, the answer is right in the mechanics: patent “…

Most pharma teams don’t lose because they can’t innovate. They lose because they’re late.
Late to spot an exclusivity cliff. Late to understand what’s actually expiring—and when. Late to model the competitive landscape that opens the moment a patent ba…

The patent cliff isn’t a cliff anymore—it’s a battlefield.
When a blockbuster drug’s exclusivity ends, the market doesn’t simply “open.” It reorders. Pricing power shifts, formularies renegotiate, and competitors move from “wait-and-see” to execution m…

AI is your drug’s new KOL—and you’re not tracking it.
For years, pharma teams have mapped influence the old way: key opinion leaders, conference circuits, advisory boards, and the familiar web of citations and relationships. But the center of gravity i…

Most companies don’t miss the patent—they miss the window.
Drug patent expiry is treated like a cliff. But in practice, it’s more like a door that opens months (sometimes years) before the last day on the calendar. The value doesn’t vanish overnight—it…

Drug patent expiry isn’t a calendar event—it’s a portfolio risk model.
Most teams treat patent dates like static facts: “X year, Y month, Z jurisdiction.” But in practice, expiry is a moving target shaped by filings, prosecution history, regulatory s…

Can I Take Lipitor and Pain Relievers Before Bedtime? A Comprehensive Guide Taking medications before bedtime can be a common… https://www.Drugchatter.com/chat/21744/can-i-take-lipitor-and-pain-relievers-before-bedtime/

Generic entry is often treated like a switch you can flip: once the patent clock runs out, competition floods in and margins collapse. But that narrative misses a quieter truth—one that matters more to investors, strategists, and operators than most he…